Adial Pharmaceuticals Ownership | Who Owns Adial Pharmaceuticals?

Adial Pharmaceuticals Ownership Summary

Adial Pharmaceuticals is owned by 0.89% institutional investors, 7.99% insiders, and 91.12% retail investors. Vanguard group is the largest institutional shareholder, holding 0.70% of ADIL shares. Fidelity Extended Market Index is the top mutual fund, with 1.66% of its assets in Adial Pharmaceuticals shares.

ADIL Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Adial Pharmaceuticals	0.89%	7.99%	91.12%
Sector	Healthcare Stocks	35.58%	11.87%	52.55%
Industry	Biotech Stocks	35.75%	11.83%	52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	156.02K	0.70%	$34.33K
Vanguard fiduciary trust	5.88K	0.53%	$10.52K
Caitong asset management	15.00	0.00%	$27.00
Northwestern mutual wealth management	4.00	0.00%	$7.00
Jane street group	-	-	-
Two sigma investments, lp	-	-	-
Tower research capital llc (trc)	-	-	-
Susquehanna group, llp	-	-	-
Northern trust	-	-	-
Harbour investments	-	-	-

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Manchester capital management	-	-	-
Tower research capital llc (trc)	-	-	-
Two sigma securities	-	-	-
Susquehanna group, llp	-	-	-
Jane street group	-	-	-
Two sigma investments, lp	-	-	-
Harbour investments	-	-	-
Northern trust	-	-	-
Northwestern mutual wealth management	4.00	-	$7.00
Geode capital management	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Vanguard fiduciary trust	5.88K	-	5.88K
Caitong asset management	15.00	-	15.00
Northwestern mutual wealth management	4.00	-	4.00
Vanguard group	156.02K	-	-
Morgan stanley	-	-	-9.00

Top Sellers

Holder	Shares	% Assets	Change
Armistice capital	-	-	-2.55M
Citadel advisors	-	-	-219.62K
Geode capital management	-	-	-155.75K
Jane street group	-	-	-121.84K
Northern trust	-	-	-65.98K

New Positions

Holder	Shares	% Assets	Change	Value
Vanguard fiduciary trust	5.88K	-	5.88K	$10.52K
Caitong asset management	15.00	-	15.00	$27.00
Northwestern mutual wealth management	4.00	-	4.00	$7.00

Sold Out

Holder	Change
Morgan stanley	-9.00
Abound wealth management	-27.00
Harbour investments	-99.00
Wells fargo & company/mn	-160.00
Sbi securities	-1.16K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	10	-54.55%	9,888	-99.72%	-	0.35%	4	-63.64%	6	50.00%
Dec 31, 2025	13	-18.75%	549,548	-9.63%	2	32.95%	3	-62.50%	3	-
Sep 30, 2025	16	6.67%	608,084	159.09%	5	117.27%	9	28.57%	3	50.00%
Jun 30, 2025	16	23.08%	234,705	-1.48%	2	134.51%	7	16.67%	2	100.00%
Mar 31, 2025	1	-	3,600	-	-	508.75%	-	-100.00%	-	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Extended Market Index	23.68K	1.66%	18.41K
BlackRock Extended Equity Market K	17.57K	0.27%	-7.00
Northern Trust Extended Eq Market Idx	2.62K	0.18%	2.59K
NT Ext Equity Mkt Idx Fd - L	2.62K	0.18%	-
NT Ext Equity Mkt Index Fund - Lending	2.62K	0.17%	-
Spartan Extended Market Index Pool E	11.33K	0.17%	295.00
NT Ext Eq Mkt Indx Fd DC Lending Tier 5	1.03K	0.07%	7.00
NT Ext Eq Mkt Idx Fd DC Lending Tier 5	1.03K	0.07%	7.00
Extended Equity Market Fund B	20.16K	0.06%	-
Extended Equity Market Fund E	20.16K	0.06%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 29, 2023	Schuyler Kevin	-	Buy	$1.92K
Dec 30, 2021	Newman James W. Jr.	-	Buy	$27.10K
Dec 30, 2021	Newman James W. Jr.	-	Buy	$13.60K
Dec 30, 2021	Newman James W. Jr.	-	Buy	$26.60K
Nov 30, 2021	Stilley William B. III	Chief Executive Officer	Buy	$29.18K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	-
2024 Q1	-	-
2023 Q3	1	-
2023 Q2	-	-
2022 Q4	-	-

ADIL Ownership FAQ

Who Owns Adial Pharmaceuticals?

Adial Pharmaceuticals shareholders are primarily institutional investors at 0.89%, followed by 7.99% insiders and 91.12% retail investors. The average institutional ownership in Adial Pharmaceuticals's industry, Biotech Stocks , is 35.75%, which Adial Pharmaceuticals falls below.

Who owns the most shares of Adial Pharmaceuticals?

Adial Pharmaceuticals’s largest shareholders are Vanguard group (156.02K shares, 0.70%), Vanguard fiduciary trust (5.88K shares, 0.53%), and Caitong asset management (15 shares, 0.00%). Together, they hold 1.23% of Adial Pharmaceuticals’s total shares outstanding.

Does Blackrock own Adial Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Adial Pharmaceuticals.

Who is Adial Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Manchester capital management is Adial Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Adial Pharmaceuticals shares, valued at 0$.

Who is the top mutual fund holder of Adial Pharmaceuticals shares?

Fidelity Extended Market Index is the top mutual fund holder of Adial Pharmaceuticals shares, with 1.66% of its total shares outstanding invested in 23.68K Adial Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools